{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-010802","form_type":"8-K","ticker":"CHRS","cik":"0001512762","company_name":"Coherus Oncology, Inc.","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.177532+00:00","generated_at":"2026-05-17T17:28:46.568783+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Coherus Q2 LOQTORZI rev $10M (+36% QoQ); UDENYCA divestiture closed for $483M","bullets":["LOQTORZI net revenue $10.0M in Q2 2025, up 36% from $7.3M in Q1 2025 and $3.8M in Q2 2024.","UDENYCA divestiture completed April 11, 2025; Coherus received $483.4M cash and is eligible for up to $75M milestones.","Used proceeds to repay substantially all $230M of 2026 Convertible Notes and buy out royalty rights for $47.7M.","Q2 2025 net loss from continuing ops $44.9M ($0.39 diluted loss) vs $54.9M ($0.48) YoY; non-GAAP net loss $39.0M.","Cash, cash equivalents and marketable securities $238M at June 30, 2025; CHS-114 and casdozokitug data readouts expected 1H 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-010802","json":"https://secwatch.observer/filing/0001558370-25-010802.json","markdown":"https://secwatch.observer/filing/0001558370-25-010802.md","text":"https://secwatch.observer/filing/0001558370-25-010802.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512762/000155837025010802/0001558370-25-010802-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512762/000155837025010802/chrs-20250807x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T17:28:46.568783+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}